Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value Chain
X
Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value Chain
XSign in

Market Pulse

Daily · Nov 5, 2026 · data.go.kr + ECOS
KOSPI
5,383.80
-300.00 (-5.28%)
KOSDAQ
678.41
-36.54 (-5.11%)
KOSPI 200
837.78
-51.47 (-5.79%)
USD/KRW
1,342.10
Home›Reports›128940
128940KOSPI·Nov 02, 2026

Third deal this year; focus now turns to Merck��s data readout

Hanmi Pharm. Co., Ltd.Mirae Asset SecuritiesSeung-min Kim
Read original PDF ↗
HP
Source
Mirae Asset Securities
Type
Company Analysis
Language
English
Rating
Buy
Target price
-
Collected
Nov 08, 2026
The full report is published by Mirae Asset Securities. Korean Tickers provides its source link and metadata.

More research on 128940

Concerns appear to be peakingMirae Asset Securities · Oct 28, 2026Roche��s answer to Eli Lilly and Novo NordiskMirae Asset Securities · Aug 26, 2026Focus on Beijing Hanmi��s recovery and pipeline progressMirae Asset Securities · Jul 29, 2026Eli Lilly deal adds to pipeline valueMirae Asset Securities · Jun 04, 2026Sailing With LillyKB Securities · Jun 02, 2026Initiating Coverage: Core Business Recovery; Obesity, R&D NextKB Securities · May 27, 2026
All reports for 128940 →

Advertisement

Korean Tickers·Research reference for Korean listed companies.
Prices use KIS quote snapshots with data.go.kr daily fallback. Financials use DART; macro data uses ECOS.·Market data is informational and not investment advice.
KIS snapshots are refreshed every 30 minutes and are not a streaming quote feed.·Sources
TermsRefundsDisclaimerPrivacy